HELP Latest Press Releases

-- March 12, 2026 --

Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer Globe Newswire 7:30 AM

-- March 5, 2026 --

Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder Globe Newswire 7:30 AM

-- February 24, 2026 --

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee Globe Newswire 7:45 AM

-- February 17, 2026 --

Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder Globe Newswire 7:30 AM

-- February 13, 2026 --

HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights Globe Newswire 7:31 AM

-- February 10, 2026 --

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution Globe Newswire 7:30 AM

-- January 5, 2026 --

HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq Business Wire 7:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software